Dental Considerations in Patients with Oral Mucosal Diseases

被引：0
作者：
Sherrell, Wesley [1 ]
Desai, Bhavik [2 ]
Sollecito, Thomas P. [3 ]
机构：
[1] Univ N Carolina, Adams Sch Dent, Oral Med, Div Diagnost Sci, Campus Box 7450, Chapel Hill, NC 27599 USA
[2] Affiliated Hlth Wisconsin, Milwaukee, WI USA
[3] Univ Penn, Dept Oral Med, Sch Dent Med, 240 South 40th St,Suite 200, Philadelphia, PA 19104 USA
来源：
DERMATOLOGIC CLINICS | 2020年 / 38卷 / 04期
关键词：
Dental considerations; Oral mucosal diseases; Topical agents; Malignant transformation; Caries risk and prevention; LICHEN-PLANUS; THERAPY; ASSOCIATION; INFECTIONS; MANAGEMENT; INHIBITORS; LESIONS; CANCER; RISK; CARE;
D O I：
10.1016/j.det.2020.05.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Oral mucosal diseases represent a significant health care burden, rendering a complex patient population in which interdisciplinary care among dermatologists, primary dental providers, and dental specialists is required for optimal care. Oral mucosal diseases often cause painful ulceration and blistering which can impede a patient's ability to perform dental home care and the dental professional's ability to deliver routine and complex treatment. It is crucial to consider the environment of the oral cavity. It is paramount to be aware of the potential side effects that certain medications may cause and the possible interactions with other medications the patient is using. © 2020 Elsevier Inc.
引用
收藏
页码：535 / 541
页数：7
相关论文
共 42 条
[1]   Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis [J].
Baecklund, Eva ;
Backlin, Carin ;
Iliadou, Anastasia ;
Granath, Fredrik ;
Ekbom, Anders ;
Amini, Rose-Marie ;
Feltelius, Nils ;
Enblad, Gunilla ;
Sundstrom, Christer ;
Klareskog, Lars ;
Askling, Johan ;
Rosenquist, Richard .
ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3774-3781
[2]   Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders [J].
Bagg, Adam ;
Dunphy, Cherie H. .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2013, 30 (02) :102-112
[3]   The use of topical calcineurin inhibitors in dermatology: Safety concerns - Report of the American Academy of Dermatology Association Task Force [J].
Berger, TG ;
Duvic, M ;
Van Voorhees, AS ;
Frieden, IJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) :818-823
[4]   Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].
Bongartz, T ;
Sutton, AJ ;
Sweeting, MJ ;
Buchan, I ;
Matteson, EL ;
Montori, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285
[5]   Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up [J].
Carbone, M ;
Goss, E ;
Carrozzo, M ;
Castellano, S ;
Conrotto, D ;
Broccoletti, R ;
Gandolfo, S .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (06) :323-329
[6]   A retrospective study of the management of oral mucous membrane pemphigoid with dapsone [J].
Ciarrocca, KN ;
Greenberg, MS .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1999, 88 (02) :159-163
[7]   Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition? [J].
Clayton, R. ;
Chaudhry, S. ;
Ali, I. ;
Cooper, S. ;
Hodgson, T. ;
Wojnarowska, F. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (04) :384-387
[8]   DAPSONE - MODES OF ACTION, TOXICITY AND POSSIBLE STRATEGIES FOR INCREASING PATIENT TOLERANCE [J].
COLEMAN, MD .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (05) :507-513
[9]   Results of patch testing to a corticosteroid series: A retrospective review of 1188 patients during 6 years at Mayo Clinic [J].
Davis, Mark D. P. ;
el-Azhary, Rokea A. ;
Farmer, Sara A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (06) :921-927
[10]  
Dowd F J, 1999, Dent Clin North Am, V43, P579
12345